glutathione bromopyruvic acid conjugate Phase II - Conjugation | Metabolism of Herbicides or Xenobiotics in Plants 3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes
3 Bromopyruvate mediated MCT1 dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation Cancer & Metabolism Springer Nature Link 3 Bromopyruvate (3 Bromopyruvic acid) (Hexokinase II Inhibitor II; 3 BP) CAS 1113 59 3 AbMole BioScience 3 Bromopyruvate (3 Bromopyruvic acid) Price 3 Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy dependent ferroptosis Cancer Gene Therapy The promising anticancer drug 3 bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence based view ScienceDirect
Pay in 4 interest-free payments of $5.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



